Assembly Biosciences
Devin Bradley is a finance professional with extensive experience in financial planning and analysis (FP&A) and assurance services. Currently serving as a Senior Manager, FP&A at Assembly Biosciences, Inc. since March 2020, Devin has held progressive roles within the company, including Manager and Senior Analyst in FP&A. Prior to this, Devin worked at EY from September 2016 to February 2020 as a Senior Assurance Associate, following a brief stint as a Fulfillment Specialist at Farm Hill and multiple roles at EY as a Campus Ambassador and Assurance Intern. Early career experience includes serving as an Assistant Foreman at Mid Penninsula Roofing Inc. Devin earned a Bachelor of Science in Accounting and Business/Management from the School of Business at Sonoma State University and holds a Bachelor's degree in Sports Finance from Coastal Carolina University, along with an Associate's degree from the College of San Mateo.
Assembly Biosciences
9 followers
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets.